#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15002	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2531	730.3	0	.	n	.	0	C1512T	SNP	1512	1512	C	1976	1976	T	917	T,C,A	459,457,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15002	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2531	730.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1648	1648	C	1003	C,G,T,A	1000,1,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25806	23S	2890	2890	99.83	23S.l6.c4.ctg.1	4010	801.8	0	.	n	.	0	T695C	SNP	695	695	T	1261	1261	C	1009	C,T,G	1005,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25806	23S	2890	2890	99.83	23S.l6.c4.ctg.1	4010	801.8	0	.	n	.	0	A914G	SNP	914	914	A	1480	1480	G	989	G,A,T	721,267,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25806	23S	2890	2890	99.83	23S.l6.c4.ctg.1	4010	801.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1903	1903	A	1017	A,G	1016,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25806	23S	2890	2890	99.83	23S.l6.c4.ctg.1	4010	801.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2537	2537	C	871	C,T	870,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25806	23S	2890	2890	99.83	23S.l6.c4.ctg.1	4010	801.8	0	.	n	.	0	C1992T	SNP	1992	1992	C	2558	2558	T	877	T,C	427,450	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25806	23S	2890	2890	99.83	23S.l6.c4.ctg.1	4010	801.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2611	2611	A	881	A,G	880,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25806	23S	2890	2890	99.83	23S.l6.c4.ctg.1	4010	801.8	1	SNP	n	C2597T	0	.	.	2597	2597	C	3163	3163	C	930	C,T	928,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	16	22	blaTEM	861	354	100.0	blaTEM.l15.c30.ctg.1	764	2.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	27	2118	folP	855	855	100.0	folP.l15.c17.ctg.1	1871	140.7	1	SNP	p	R229S	0	.	.	685	687	CGC	1189	1191	CGC	219;221;221	C;G;C	219;221;221	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4768	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3978	149.3	1	SNP	p	S91F	0	.	.	271	273	TCC	893	895	TCC	173;174;172	T;C;C	173;174;172	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4768	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3978	149.3	1	SNP	p	D95N	0	.	.	283	285	GAC	905	907	GAC	168;168;167	G,A;A;C,A	167,1;168;166,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4768	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3978	149.3	1	SNP	p	D95G	0	.	.	283	285	GAC	905	907	GAC	168;168;167	G,A;A;C,A	167,1;168;166,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	27	1824	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1627	139.4	1	SNP	p	G45D	1	.	.	133	135	GAC	632	634	GAC	216;215;213	G,T;A,G;C,G,T	215,1;214,1;211,1,1	mtrR.WHO_M_01390:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1040	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1330	97.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4870	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3433	176.5	1	SNP	p	D86N	0	.	.	256	258	GAC	809	811	GAC	217;219;216	G;A;C	215;217;214	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	4870	parC	2304	2304	99.83	parC.l15.c4.ctg.1	3433	176.5	1	SNP	p	S88P	0	.	.	262	264	TCC	815	817	TCC	218;217;219	T,G;C;C	215,1;216;218	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4082	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3068	165.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1763	1765	GGC	217;215;214	G;G;C	217;215;214	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	A311V	0	.	.	931	933	GCA	1502	1504	GCA	241;241;243	G,A,T;C;A,G	239,1,1;241;242,1	penA.22.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	I312M	0	.	.	934	936	ATC	1505	1507	ATC	241;243;242	A;T;C,G	241;243;241,1	penA.22.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	V316P	0	.	.	946	948	GTG	1517	1519	GTG	244;247;248	G;T;G	244;247;248	penA.22.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	V316T	0	.	.	946	948	GTG	1517	1519	GTG	244;247;248	G;T;G	244;247;248	penA.22.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2021	2023	ACC	205;205;205	A;C,A;C	205;204,1;205	penA.22.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2075	2077	GCG	218;217;219	G,T;C,T,G;G	217,1;215,1,1;219	penA.22.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2075	2077	GCG	218;217;219	G,T;C,T,G;G	217,1;215,1,1;219	penA.22.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2198	2200	GGT	211;214;214	G,C;G;T,C	210,1;214;213,1	penA.22.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2207	2209	GGC	225;226;225	G;G;C,T	225;226;224,1	penA.22.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.22.001	penA.22.001	1	1	27	3868	penA	1752	1752	100.0	penA.l6.c4.ctg.1	2878	167.7	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2225	2227	CCG	225;223;224	C;C,A;G,T,C	225;222,1;222,1,1	penA.22.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5226	ponA	2397	2397	99.96	ponA.l15.c17.ctg.1	3694	176.4	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1937	1939	CCG	188;187;188	C,T;C,A;G	187,1;186,1;188	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2276	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2259	125.2	0	.	p	.	0	S22G	NONSYN	64	66	AGC	624	626	GGC	150;150;150	G,A;G;C	149,1;150;150	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2276	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2259	125.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	806	806	C	190	C,G	189,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	342	porB1a	984	291	90.17	porB1a.l6.c30.ctg.1	995	30.3	0	.	p	.	0	H217N	NONSYN	649	651	CAT	729	731	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	342	porB1a	984	291	90.17	porB1a.l6.c30.ctg.1	995	30.3	0	.	p	.	0	D218N	NONSYN	652	654	GAT	732	734	AAT	5;5;5	A;A;T	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	342	porB1a	984	291	90.17	porB1a.l6.c30.ctg.1	995	30.3	0	.	p	.	0	A222V	NONSYN	664	666	GCT	744	746	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	342	porB1a	984	291	90.17	porB1a.l6.c30.ctg.1	995	30.3	0	.	p	.	0	V226A	NONSYN	676	678	GTA	756	758	GCG	4;4;4	G;C;G	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	342	porB1a	984	291	90.17	porB1a.l6.c30.ctg.1	995	30.3	0	.	p	.	0	.	MULTIPLE	700	702	ACT	779	781	GTA	5;6;6	G;T;A	5;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	342	porB1a	984	291	90.17	porB1a.l6.c30.ctg.1	995	30.3	0	.	p	.	0	D238fs	FSHIFT	712	712	G	791	791	G	6	G	6	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	D41Y	NONSYN	121	123	GAC	624	626	TAC	242;242;243	T,G,A;A,C;C,A	240,1,1;240,2;242,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	A54S	NONSYN	160	162	GCC	663	665	TCC	269;268;270	T;C;C	269;268;270	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	A109V	NONSYN	325	327	GCC	828	830	GTC	255;258;254	G,T;T,G;C	254,1;257,1;254	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	894	896	TAT	255;256;249	T;A;T,C	255;256;248,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	N134E	NONSYN	400	402	AAT	903	905	GAG	254;253;249	G;A;G,T	254;253;248,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	V135F	NONSYN	403	405	GTG	906	908	TTT	247;245;245	T;T;T,C	247;245;244,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	G140K	NONSYN	418	420	GGA	921	923	AAA	232;229;227	A;A;A,T	232;229;226,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	K143G	NONSYN	427	429	AAA	930	932	GGA	219;219;220	G;G,T;A	219;218,1;220	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	954	956	GCA	237;238;237	G,C;C;A,G	236,1;238;235,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	E212D	NONSYN	634	636	GAA	1137	1139	GAT	278;276;276	G,T;A,C;T	276,1;274,1;275	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	H213G	NONSYN	637	639	CAT	1140	1142	GGT	276;274;273	G;G;T	275;273;273	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	V215A	NONSYN	643	645	GTT	1146	1148	GCT	262;260;260	G;C;T,C	262;260;259,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	I218M	NONSYN	652	654	ATC	1155	1157	ATG	268;265;263	A;T,C;G,C	268;264,1;262,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	R257T	NONSYN	769	771	AGG	1272	1274	ACG	220;218;221	A;C;G	220;218;221	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	A259V	NONSYN	775	777	GCT	1278	1280	GTT	216;212;210	G,T,C;T,G,A;T	214,1,1;210,1,1;210	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1392	1394	AAC	217;216;215	A,G;A;C,T	216,1;216;213,2	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2884	porB1b	1047	1047	97.33	porB1b.l6.c4.ctg.1	2081	171.8	1	SNP	p	G120K	0	.	.	358	360	GGC	861	863	GGC	240;240;240	G;G;C	239;239;240	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	268	porB3	990	162	93.83	porB3.l15.c17.ctg.3	164	45.0	0	.	p	.	0	S273T	NONSYN	817	819	TCG	62	64	ACT	59;59;59	A;C;T	59;59;59	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	268	porB3	990	162	93.83	porB3.l15.c17.ctg.3	164	45.0	0	.	p	.	0	D276S	NONSYN	826	828	GAT	71	73	AGT	59;59;59	A;G;T	59;59;59	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	268	porB3	990	162	93.83	porB3.l15.c17.ctg.3	164	45.0	0	.	p	.	0	K278N	NONSYN	832	834	AAA	77	79	AAC	59;59;59	A,G;A;C	58,1;59;59	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	268	porB3	990	162	93.83	porB3.l15.c17.ctg.3	164	45.0	0	.	p	.	0	R279H	NONSYN	835	837	CGC	80	82	CAC	59;59;59	C,T;A;C	58,1;59;59	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10040	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5291	236.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1434	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1514	118.0	1	SNP	p	V57M	1	.	.	169	171	ATG	732	734	ATG	243;245;243	A;T,G;G	243;244,1;242	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
